Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
AssigneeAlcon Research, Ltd.
InventorNajam A. Sharif
Life of this patent
Estimating the term…
Abstract
The invention provides methods for treating and/or preventing ocular disorders associated with increased intraocular pressure comprising administering a bradykinin B2 receptor agonist to a patient in need thereof.
Claims7
A method for treating an ocular disorder associated with elevated intraocular pressure in a patient, the method comprising administering to the patient a composition comprising a pharmaceutically acceptable ophthalmic carrier and a therapeutically effective amount of a bradykinin B2 receptor (B2R) agonist, wherein the B2R agonist is a peptide or a pseudo-peptide bradykinin agonist or a prodrug thereof, wherein the B2R agonist is administered topical ocular, sub-tenon, sub-conjunctivally, or intravitreally.
Dependencies are inferred from the claim text.